Your browser doesn't support javascript.
loading
Compared Performance of the 2023 Duke-International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort.
Goehringer, Francois; Lalloué, Benoit; Selton-Suty, Christine; Alla, François; Botelho-Nevers, Elisabeth; Chirouze, Catherine; Curlier, Elodie; El Hatimi, Safwane; Gagneux-Brunon, Amandine; le Moing, Vincent; Lim, Pascal; Piroth, Lionel; Strady, Christophe; Tribouilloy, Christophe; Virion, Jean-Marc; Agrinier, Nelly; Duval, Xavier; Hoen, Bruno.
Affiliation
  • Goehringer F; Service de maladies infectieuses et tropicales, CHRU de Nancy, Nancy, France.
  • Lalloué B; CHRU de Nancy, INSERM, CIC, Epidémiologie Clinique, Université de Lorraine, Nancy, France.
  • Selton-Suty C; Département de cardiologie médicale, CHRU de Nancy, CIC-EC, Nancy, France.
  • Alla F; INSERM, BPH, U1219, I-prev/PHARES, CIC 1401, Universite Bordeaux, Bordeaux, France.
  • Botelho-Nevers E; Service de prévention, CHU de Bordeaux, Bordeaux, France.
  • Chirouze C; Service de maladies infectieuses, CHU de Saint-Etienne, Saint-Etienne, France.
  • Curlier E; CIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université de Lyon, Inserm, U1111, CNRS, UMR530, Saint-Etienne, France.
  • El Hatimi S; Chrono-environnement UMR6249, CNRS, Université de Bourgogne Franche-Comté, Besançon, France.
  • Gagneux-Brunon A; Service de maladies infectieuses et tropicales, CHU Jean Minjoz, Besançon, France.
  • le Moing V; Service de maladies infectieuses, CHU de la Guadeloupe, Pointe-à-Pitre, France.
  • Lim P; CHU Bicêtre, Université Paris Saclay, Le Kremlin Bicêtre, France.
  • Piroth L; Service de maladies infectieuses, CHU de Saint-Etienne, Saint-Etienne, France.
  • Strady C; CIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Université Jean Monnet, Université de Lyon, Inserm, U1111, CNRS, UMR530, Saint-Etienne, France.
  • Tribouilloy C; Service de Maladies Infectieuses et Tropicales, CHU de Montpellier, Montpellier, France.
  • Virion JM; Université de Montpellier, Montpellier, France.
  • Agrinier N; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Faculté de Santé, Univ. Paris Est Créteil, Créteil, France.
  • Duval X; Service de maladies infectieuses, CHU de Dijon, Dijon, France.
  • Hoen B; CHU Dijon-Bourgogne, INSERM, CIC 1432, Module Épidémiologie Clinique, Université de Bourgogne, Dijon, France.
Clin Infect Dis ; 78(4): 937-948, 2024 Apr 10.
Article in En | MEDLINE | ID: mdl-38330171
ABSTRACT

BACKGROUND:

The 2023 Duke-International Society for Cardiovascular Diseases (ISCVID) criteria for infective endocarditis (IE) were proposed as an updated diagnostic classification of IE. Using an open prospective multicenter cohort of patients treated for IE, we compared the performance of these new criteria to that of the 2000 Modified Duke and 2015 European Society of Cardiology (ESC) criteria.

METHODS:

Cases of patients treated for IE between January 2017 and October 2022 were adjudicated as certain IE or not. Each case was also categorized as either definite or possible/rejected within each classification. Sensitivity, specificity, and accuracy were estimated with 95% confidence intervals.

RESULTS:

Of the 1194 patients analyzed (mean age, 66.1 years; 71.2% males), 414 (34.7%) had a prosthetic valve and 284 (23.8%) had a cardiac implanted electronic device (CIED); 946 (79.2%) were adjudicated as certain IE; 978 (81.9%), 997 (83.5%), and 1057 (88.5%) were classified as definite IE in the 2000 modified Duke, 2015 ESC, and 2023 Duke-ISCVID criteria, respectively. The sensitivity of each set of criteria was 93.2% (95% confidence interval [CI], 91.6-94.8), 95.0% (95% CI, 93.7-96.4), and 97.6% (95% CI, 96.6-98.6), respectively (P < .001 for all 2-by-2 comparisons). Corresponding specificity rates were 61.3% (95% CI, 55.2-67.4), 60.5% (95% CI, 54.4-66.6), and 46.0% (95% CI, 39.8-52.2), respectively. In patients without CIED, sensitivity rates were 94.8% (95% CI, 93.2-96.4), 96.5% (95% CI, 95.1-97.8), and 97.7% (95% CI, 96.6-98.8); specificity rates were 59.0% (95% CI, 51.6-66.3), 56.6% (95% CI, 49.3-64.0), and 53.8% (95% CI, 46.3-61.2), respectively.

CONCLUSIONS:

Overall, the 2023 Duke-ISCVID criteria had a significantly higher sensitivity but a significantly lower specificity compared with older criteria. This decreased specificity was mainly attributable to patients with CIED.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Cardiology / Cardiovascular Diseases / Communicable Diseases / Endocarditis / Endocarditis, Bacterial Type of study: Diagnostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Cardiology / Cardiovascular Diseases / Communicable Diseases / Endocarditis / Endocarditis, Bacterial Type of study: Diagnostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: France